Get our newsletter delivered directly to your inbox
I have already subscribed | Do not show this message again
Your email has been successfully registered.
Moderna's CEO, Stephane Bancel, said the company is working on a booster vaccine to fight the Omicron Variant on Monday.
Stephane Bancel, the CEO of Moderna pharma company, announced on Monday that they are working on an Omicron-specific booster vaccine, which is about to start on clinical trials, with a chance to be ready by autumn.
“We are discussing with public health leaders around the world to decide what we think is the best strategy for the potential booster for the fall of 2022. We believe it will contain omicron,” he told CNBC’s “Squawk Box” on Monday.
Bancel says they are studying the shots to see if they have any other component to strike the virus. “We need to be careful to try to stay ahead of a virus and not behind the virus,” he stressed.
Moderna has already signed agreements with the United Kingdom, South Korea and Switzerland with upfront payments worth $18.5 billion of shots orders for this fall. “There are discussions ongoing on a daily basis. We want to be ready with the best product possible for the fall of ’22,” the CEO of Moderna said on Monday.
"Lowest Covid deaths with Moderna vaccines, highest with Sinovac shots, claims Singapore data" https://t.co/xLi1PKkqHz